Prudentia Sciences
PrivateLast Round
Series A
Jan 7, 2026
Total Funding Raised
$27M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Prudentia Sciences operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in January 2026.
Prudentia Sciences is a business/productivity software company that provides an AI-native platform for due diligence, valuation, and dealmaking for the life sciences industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Business Intelligence, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prudentia Sciences Comparables
Compare Prudentia Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| One Zyme | 85% | |
| PhaseFolio | 84% | |
| Pixen | 83% |
For institutional investors. Book with your work email.
Prudentia Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 7, 2026 | ||||
| Seed | Jan 9, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prudentia Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iaso Ventures | Series A, Seed |
| GV | Series A, Seed |
| McKesson Ventures | Series A |
| McKesson Ventures | Series A |
| SignalFire | Series A |
| Virtue | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2026
Open roles increased to 64, 2.56x headcount.
- Oct 6, 2026
Open roles increased to 44, 1.83x headcount.
For institutional investors. Book with your work email.
Prudentia Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Prudentia Sciences's valuation, stock price, and market status.
Is Prudentia Sciences a public or private company?
Prudentia Sciences is a private company.
What is the current stock price of Prudentia Sciences?
Prudentia Sciences is a private company, so its shares have no public market price. Caplight tracks Prudentia Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prudentia Sciences worth (valuation)?
Valuation information for Prudentia Sciences is not publicly available.
Can I buy Prudentia Sciences stock?
Prudentia Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prudentia Sciences's last funding round?
Prudentia Sciences's most recent funding round was Series A on January 7, 2026.
Who are the main investors in Prudentia Sciences?
Key investors in Prudentia Sciences include GV, McKesson Ventures, McKesson Ventures.
Will Prudentia Sciences IPO soon?
No public IPO plans have been announced for Prudentia Sciences.
How can I track Prudentia Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Prudentia Sciences's shares on secondary markets.